NCT00062491 2020-03-12Study of Karenitecin (BNP1350) to Treat Malignant MelanomaBioNumerik Pharmaceuticals, Inc.Phase 2 Completed46 enrolled
NCT00477282 2020-03-12Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian CancerBioNumerik Pharmaceuticals, Inc.Phase 3 Completed509 enrolled